CVS Health Files Q3 2024 10-Q
Ticker: CVS · Form: 10-Q · Filed: Nov 6, 2024 · CIK: 64803
| Field | Detail |
|---|---|
| Company | Cvs Health CORP (CVS) |
| Form Type | 10-Q |
| Filed Date | Nov 6, 2024 |
| Risk Level | low |
| Pages | 16 |
| Reading Time | 19 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, financials, quarterly-report
TL;DR
CVS Health dropped its Q3 2024 10-Q. Check financials.
AI Summary
CVS Health Corp. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter of 2024 and provides financial updates for the company. Specific financial figures and operational details for the quarter and year-to-date are detailed within the report.
Why It Matters
This filing provides investors and analysts with the latest financial performance data for CVS Health, crucial for understanding the company's current health and future prospects.
Risk Assessment
Risk Level: low — This is a routine quarterly financial filing with no immediate red flags.
Key Players & Entities
- CVS HEALTH Corp (company) — Filer
- 0000064803-24-000034 (filing_id) — Accession Number
- 20240930 (date) — Period of Report
- 20241106 (date) — Filed as of Date
- WOONSOCKET, RI (location) — Business Address
FAQ
What is the reporting period for this 10-Q filing?
The Conformed Period of Report is 20240930, indicating the filing covers the period ending September 30, 2024.
When was this 10-Q filed with the SEC?
This 10-Q was filed as of date 20241106.
What is the company's Central Index Key (CIK)?
The Central Index Key for CVS HEALTH Corp is 0000064803.
What is the Standard Industrial Classification (SIC) code for CVS Health?
The SIC code is [5912], which corresponds to RETAIL-DRUG STORES AND PROPRIETARY STORES.
What is the fiscal year end for CVS Health?
The fiscal year end for CVS Health is 1231.
Filing Stats: 4,700 words · 19 min read · ~16 pages · Grade level 20 · Accepted 2024-11-06 06:35:35
Key Financial Figures
- $0.01 — ich registered Common Stock, par value $0.01 per share CVS New York Stock Exchange
Filing Documents
- cvs-20240930.htm (10-Q) — 3066KB
- a09302024ex151.htm (EX-15.1) — 3KB
- a09302024ex311.htm (EX-31.1) — 10KB
- a09302024ex312.htm (EX-31.2) — 9KB
- a09302024ex321.htm (EX-32.1) — 5KB
- a09302024ex322.htm (EX-32.2) — 5KB
- cvs-20240930_g1.jpg (GRAPHIC) — 4KB
- 0000064803-24-000034.txt ( ) — 14926KB
- cvs-20240930.xsd (EX-101.SCH) — 80KB
- cvs-20240930_cal.xml (EX-101.CAL) — 136KB
- cvs-20240930_def.xml (EX-101.DEF) — 401KB
- cvs-20240930_lab.xml (EX-101.LAB) — 923KB
- cvs-20240930_pre.xml (EX-101.PRE) — 649KB
- cvs-20240930_htm.xml (XML) — 3216KB
Financial Information
Part I Financial Information
Financial Statements
Item 1. Financial Statements 1
Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 48
Quantitative and Qualitative Disclosures About Market Risk
Item 3. Quantitative and Qualitative Disclosures About Market Risk 72
Controls and Procedures
Item 4. Controls and Procedures 72
Other Information
Part II Other Information
Legal Proceedings
Item 1. Legal Proceedings 73
Risk Factors
Item 1A. Risk Factors 73
Unregistered Sales of Equity Securities and Use of Proceeds
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 73
Defaults Upon Senior Securities
Item 3 Defaults Upon Senior Securities 73
Mine Safety Disclosures
Item 4. Mine Safety Disclosures 73
Other Information
Item 5. Other Information 73
Exhibits
Item 6. Exhibits 74
Signatures
Signatures 75 Form 10-Q Table of Contents
Financial Information
Part I. Financial Information
Financial Statements
Item 1. Financial Statements Index to Condensed Consolidated Financial Statements Page Condensed Consolidated Statements of Operations (Unaudited) for the three and nine months ended September 30, 2024 and 2023 2 Condensed Consolidated Statements of Comprehensive Income (Unaudited) for the three and nine months ended September 30, 2024 and 2023 3 Condensed Consolidated Balance Sheets (Unaudited) as of September 30, 2024 and December 31, 2023 4 Condensed Consolidated Statements of Cash Flows (Unaudited) for the nine months ended September 30, 2024 and 2023 5 Condensed Consolidated Statements of Shareholders' Equity (Unaudited) for the three months ended September 30, 2024 and 2023, the three months ended June 30, 2024 and 2023 and the three months ended March 31, 2024 and 2023 7 Notes to Condensed Consolidated Financial Statements (Unaudited) 9 Report of Independent Registered Public Accounting Firm 47 1 Index to Condensed Consolidated Financial Statements CVS Health Corporation Condensed Consolidated Statements of Operations (Unaudited) Three Months Ended September 30, Nine Months Ended September 30, In millions, except per share amounts 2024 2023 2024 2023 Revenues: Products $ 59,674 $ 61,298 $ 169,610 $ 179,984 Premiums 30,925 24,657 91,983 74,117 Services 4,279 3,532 12,108 8,977 Net investment income 550 277 1,398 885 Total revenues 95,428 89,764 275,099 263,963 Operating costs: Cost of products sold 52,948 54,688 151,019 159,679 Health care costs 29,922 21,499 85,578 63,729 Operating expenses 10,557 9,876 31,185 29,329 Restructuring charges 1,169 11 1,169 507 Loss on assets held for sale — — — 349 Total operating costs 94,596 86,074 268,951 253,593 Operating income 832 3,690 6,148 10,370 Interest expense 752 693 2,200 1,968 Other income ( 25 ) ( 22 ) ( 74 ) ( 66 ) Income before income tax provision 105 3,019 4,022 8,468 Income tax provision 34 754 1,059 2,147 Net income 71 2,265 2,963 6,321 Net (income)